Adverum Clinical Site 159 — Tucson, Arizona

Adverum Clinical Site 159 is a clinical research site located in Tucson, Arizona, United States 85704.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Adverum Clinical Site 159 has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD, Neovascular Age-related Macular Degeneration.

Sponsors: Adverum Biotechnologies, Inc..

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Adverum Clinical Site 159?

Adverum Clinical Site 159 has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Adverum Clinical Site 159 conducted?

Adverum Clinical Site 159 has 2 clinical trials on record, with 2 currently active. Their work covers Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD, Neovascular Age-related Macular Degeneration.

Is Adverum Clinical Site 159 accredited by Crixeo Health?

Adverum Clinical Site 159 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Adverum Clinical Site 159?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.